| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4295498
[patent_doc_number] => 06197765
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Use of diazoxide for the treatment of metabolic syndrome and diabetes complications'
[patent_app_type] => 1
[patent_app_number] => 9/327965
[patent_app_country] => US
[patent_app_date] => 1999-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2426
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197765.pdf
[firstpage_image] =>[orig_patent_app_number] => 327965
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/327965 | Use of diazoxide for the treatment of metabolic syndrome and diabetes complications | Jun 7, 1999 | Issued |
| 09/324552 | METHODS AND COMPOSITIONS FOR TREATING ASTHMA, ATHEROSCLEROSIS AND INFLAMMATORY DISEASES USING OPTICALLY PURE (+)-ZILEUTON | Jun 2, 1999 | Abandoned |
Array
(
[id] => 4175208
[patent_doc_number] => 06083975
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Substituted benzo[1,4]dioxines as antiobesity agents'
[patent_app_type] => 1
[patent_app_number] => 9/324471
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4851
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083975.pdf
[firstpage_image] =>[orig_patent_app_number] => 324471
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/324471 | Substituted benzo[1,4]dioxines as antiobesity agents | May 31, 1999 | Issued |
Array
(
[id] => 4132746
[patent_doc_number] => 06034126
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Method for treating glycol poisoning'
[patent_app_type] => 1
[patent_app_number] => 9/317693
[patent_app_country] => US
[patent_app_date] => 1999-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1948
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/034/06034126.pdf
[firstpage_image] =>[orig_patent_app_number] => 317693
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/317693 | Method for treating glycol poisoning | May 23, 1999 | Issued |
Array
(
[id] => 4420593
[patent_doc_number] => 06177421
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-23
[patent_title] => 'Amoxicillin and clavulanate composition'
[patent_app_type] => 1
[patent_app_number] => 9/304786
[patent_app_country] => US
[patent_app_date] => 1999-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2347
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/177/06177421.pdf
[firstpage_image] =>[orig_patent_app_number] => 304786
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/304786 | Amoxicillin and clavulanate composition | May 3, 1999 | Issued |
| 09/302924 | TREATMENT OF CONGESTIVE HEART FAILURE | Apr 29, 1999 | Abandoned |
Array
(
[id] => 4235790
[patent_doc_number] => 06075045
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-13
[patent_title] => 'Method of treating paralysis of the extremities caused by cerebral infarction'
[patent_app_type] => 1
[patent_app_number] => 9/300456
[patent_app_country] => US
[patent_app_date] => 1999-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3844
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/075/06075045.pdf
[firstpage_image] =>[orig_patent_app_number] => 300456
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/300456 | Method of treating paralysis of the extremities caused by cerebral infarction | Apr 27, 1999 | Issued |
Array
(
[id] => 4134462
[patent_doc_number] => 06121311
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Method for treating cocainism'
[patent_app_type] => 1
[patent_app_number] => 9/301404
[patent_app_country] => US
[patent_app_date] => 1999-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7796
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121311.pdf
[firstpage_image] =>[orig_patent_app_number] => 301404
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/301404 | Method for treating cocainism | Apr 27, 1999 | Issued |
Array
(
[id] => 4156077
[patent_doc_number] => 06103703
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure'
[patent_app_type] => 1
[patent_app_number] => 9/300107
[patent_app_country] => US
[patent_app_date] => 1999-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7516
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103703.pdf
[firstpage_image] =>[orig_patent_app_number] => 300107
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/300107 | Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure | Apr 26, 1999 | Issued |
Array
(
[id] => 6538113
[patent_doc_number] => 20020193413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'USE OF PANAVERIUM BROMIDE FOR PREVENTING CELL PROLIFERATION AND DISEASES CAUSED THEREBY IN THE LIVER AND DIGESTIVE TRACT'
[patent_app_type] => new
[patent_app_number] => 09/180305
[patent_app_country] => US
[patent_app_date] => 1999-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1661
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09180305
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/180305 | Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract | Apr 25, 1999 | Issued |
Array
(
[id] => 4137420
[patent_doc_number] => 06015793
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-18
[patent_title] => 'Use of tagatose to enhance key blood factors'
[patent_app_type] => 1
[patent_app_number] => 9/299023
[patent_app_country] => US
[patent_app_date] => 1999-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1028
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/015/06015793.pdf
[firstpage_image] =>[orig_patent_app_number] => 299023
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/299023 | Use of tagatose to enhance key blood factors | Apr 25, 1999 | Issued |
Array
(
[id] => 4171603
[patent_doc_number] => 06140350
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Method for controlling ectoparasites'
[patent_app_type] => 1
[patent_app_number] => 9/296382
[patent_app_country] => US
[patent_app_date] => 1999-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2071
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140350.pdf
[firstpage_image] =>[orig_patent_app_number] => 296382
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/296382 | Method for controlling ectoparasites | Apr 22, 1999 | Issued |
Array
(
[id] => 4072294
[patent_doc_number] => 06069147
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-30
[patent_title] => 'Thermogenesis stimulating drugs'
[patent_app_type] => 1
[patent_app_number] => 9/286301
[patent_app_country] => US
[patent_app_date] => 1999-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2022
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/069/06069147.pdf
[firstpage_image] =>[orig_patent_app_number] => 286301
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/286301 | Thermogenesis stimulating drugs | Apr 5, 1999 | Issued |
Array
(
[id] => 4418541
[patent_doc_number] => 06194400
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Use of amino acid precursors for the treatment of addictions'
[patent_app_type] => 1
[patent_app_number] => 9/283228
[patent_app_country] => US
[patent_app_date] => 1999-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2694
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194400.pdf
[firstpage_image] =>[orig_patent_app_number] => 283228
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/283228 | Use of amino acid precursors for the treatment of addictions | Mar 31, 1999 | Issued |
| 09/281892 | VIRAL TREATMENT | Mar 30, 1999 | Abandoned |
| 09/281896 | VIRAL TREATMENT | Mar 30, 1999 | Abandoned |
Array
(
[id] => 4239869
[patent_doc_number] => 06090849
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry'
[patent_app_type] => 1
[patent_app_number] => 9/273651
[patent_app_country] => US
[patent_app_date] => 1999-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3103
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090849.pdf
[firstpage_image] =>[orig_patent_app_number] => 273651
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/273651 | Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry | Mar 22, 1999 | Issued |
Array
(
[id] => 4288929
[patent_doc_number] => 06211217
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Method for reducing pericardial fibrosis and adhesion formation'
[patent_app_type] => 1
[patent_app_number] => 9/270412
[patent_app_country] => US
[patent_app_date] => 1999-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 7961
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211217.pdf
[firstpage_image] =>[orig_patent_app_number] => 270412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/270412 | Method for reducing pericardial fibrosis and adhesion formation | Mar 15, 1999 | Issued |
Array
(
[id] => 4295135
[patent_doc_number] => 06180666
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-30
[patent_title] => 'Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds'
[patent_app_type] => 1
[patent_app_number] => 9/264215
[patent_app_country] => US
[patent_app_date] => 1999-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7565
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/180/06180666.pdf
[firstpage_image] =>[orig_patent_app_number] => 264215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/264215 | Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds | Mar 4, 1999 | Issued |
Array
(
[id] => 4101475
[patent_doc_number] => 06066640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Hydroxy-halo-quinazolines for augmentation of mast cell bactericidal activity'
[patent_app_type] => 1
[patent_app_number] => 9/264141
[patent_app_country] => US
[patent_app_date] => 1999-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5316
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066640.pdf
[firstpage_image] =>[orig_patent_app_number] => 264141
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/264141 | Hydroxy-halo-quinazolines for augmentation of mast cell bactericidal activity | Mar 4, 1999 | Issued |